Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunosuppression After Kidney Transplantation”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Post-approval studies (Phase 4)Active Not RecruitingNCT03266393
What this trial is testing

Envarsus XR® in Adolescent Renal Transplant Recipients

Who this might be right for
Kidney TransplantationRenal TransplantationGrafting, Kidney
University of California, Los Angeles 28
Post-approval studies (Phase 4)UnknownNCT01550445
What this trial is testing

Steroid Withdrawal Immunosuppression After Renal Transplantation

Who this might be right for
Disorder Related to Renal Transplantation
Ajou University School of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT02137239
What this trial is testing

Regimen Optimization Study

Who this might be right for
Kidney Transplantation
Bristol-Myers Squibb 58
Early research (Phase 1)Study completedNCT00768729
What this trial is testing

Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation

Who this might be right for
Kidney Failure, ChronicKidney TransplantationImmunosuppression
National Institute of Allergy and Infectious Diseases (NIAID) 7
Post-approval studies (Phase 4)Study completedNCT00866879
What this trial is testing

Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients

Who this might be right for
Renal Transplant Rejection
Northwestern University 275
Post-approval studies (Phase 4)Study completedNCT01109914
What this trial is testing

Mucosal Response in Immunocompromised Host

Who this might be right for
Kidney TransplantationImmunity
Leiden University Medical Center 51
Early research (Phase 1)WithdrawnNCT03047200
What this trial is testing

Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression

Who this might be right for
Islet Cell TransplantationType 1 Diabetes
Baylor Research Institute
Large-scale testing (Phase 3)UnknownNCT03386539
What this trial is testing

Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score

Who this might be right for
Pediatric Heart TransplantationImmunosuppressionChronic Kidney Diseases+4 more
Boston Children's Hospital 211
Not applicableUnknownNCT00461357
What this trial is testing

Sirolimus Based Immunosuppression for Patients Undergoing Kidney Transplantation in the Eurotransplant Senior Program

Who this might be right for
Kidney Function After TransplantationOutcome After Kidney Transplantation
Medical University of Vienna 48
Post-approval studies (Phase 4)UnknownNCT03005236
What this trial is testing

AGe-adapted Benefits of Envarsus Versus Twice-daily Tacrolimus ImmunosuppressioN druGs After Kidney Transplantation

Who this might be right for
Kidney Transplant Failure and Rejection
University Hospital Birmingham NHS Foundation Trust 40
Not applicableStudy completedNCT04189835
What this trial is testing

EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients

Who this might be right for
EBV InfectionEBV ViremiaEpstein-Barr Virus Associated Lymphoproliferative Disorder+1 more
University of Aarhus 509
Not applicableNot Yet RecruitingNCT07231328
What this trial is testing

PIONEER Trial (Post-Transplant Application of TruGraf and TRAC Molecular Panel in Renal Transplant Recipients)

Who this might be right for
Immunosuppression ManagementBiomarkers / BloodSubclinical Rejection+2 more
Transplant Genomics, Inc. 600
Testing effectiveness (Phase 2)Ended earlyNCT02029638
What this trial is testing

BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance

Who this might be right for
Kidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 4
Post-approval studies (Phase 4)WithdrawnNCT03315052
What this trial is testing

Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects

Who this might be right for
Acute Cellular Graft RejectionLiver Transplant Rejection
Montefiore Medical Center
Post-approval studies (Phase 4)UnknownNCT01289301
What this trial is testing

Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant

Who this might be right for
Disorder Related to Renal TransplantationImmunosuppression Related Infectious DiseaseVirus Diseases
Hannover Medical School 124
Not applicableStudy completedNCT06425497
What this trial is testing

DE NOVO DONOR SPECIFIC ANTIBODIES AFTER KIDNEY TRANSPLANTATION: SINGLE-CENTER RETROSPECTIVE STUDY

Who this might be right for
Kidney Transplant; ComplicationsImmunosuppression
University of Rome Tor Vergata 600
Testing effectiveness (Phase 2)UnknownNCT00890253
What this trial is testing

Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation

Who this might be right for
Liver TransplantationChronic Renal Insufficiency
Armin Goralczyk 29
Large-scale testing (Phase 3)Ended earlyNCT04063865
What this trial is testing

Everolimus Monotherapy as Immunosuppression After Liver Transplant

Who this might be right for
Kidney Failure
Indiana University 14
Not applicableEnded earlyNCT03228576
What this trial is testing

Prospective Cohort of Kidney Transplanted Patients Receiving an Extended Releasing Tacrolimus-Everolimus Association

Who this might be right for
Kidney TransplantImmunosuppression
Poitiers University Hospital 16
Post-approval studies (Phase 4)Study completedNCT01935128
What this trial is testing

Evaluation of Calcineurin-inhibitor Reduction With Conversion at 2 Months to Everolimus/Reduced Tacrolimus in Renal Transplant Recipients Following Campath® Induction

Who this might be right for
Renal Transplant
University of Toledo Health Science Campus 55
Load More Results